171 related articles for article (PubMed ID: 38366235)
1. Co-delivery of Brinzolamide and Timolol from Micelles-laden Contact Lenses: In vitro and In Vivo Evaluation.
Yang H; Zhang F; Fan Y; Zhang J; Fang T; Xing D; Zhen Y; Nie Z; Liu Y; Wang D; Li J
Pharm Res; 2024 Mar; 41(3):531-546. PubMed ID: 38366235
[TBL] [Abstract][Full Text] [Related]
2. Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma.
Xu J; Ge Y; Bu R; Zhang A; Feng S; Wang J; Gou J; Yin T; He H; Zhang Y; Tang X
J Control Release; 2019 Jul; 305():18-28. PubMed ID: 31103677
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery.
Maulvi FA; Lakdawala DH; Shaikh AA; Desai AR; Choksi HH; Vaidya RJ; Ranch KM; Koli AR; Vyas BA; Shah DO
J Control Release; 2016 Mar; 226():47-56. PubMed ID: 26860285
[TBL] [Abstract][Full Text] [Related]
4. Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy.
Hsu KH; Carbia BE; Plummer C; Chauhan A
Eur J Pharm Biopharm; 2015 Aug; 94():312-21. PubMed ID: 26071799
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of timolol and hyaluronic acid from semi-circular ring-implanted contact lenses for the treatment of glaucoma: in vitro and in vivo evaluation.
Desai AR; Maulvi FA; Pandya MM; Ranch KM; Vyas BA; Shah SA; Shah DO
Biomater Sci; 2018 May; 6(6):1580-1591. PubMed ID: 29708242
[TBL] [Abstract][Full Text] [Related]
6. Sustained Delivery of Timolol Using Nanostructured Lipid Carriers-Laden Soft Contact Lenses.
Tian C; Zeng L; Tang L; Yu J; Ren M
AAPS PharmSciTech; 2021 Aug; 22(6):212. PubMed ID: 34378099
[TBL] [Abstract][Full Text] [Related]
7. Extended drug delivery by contact lenses for glaucoma therapy.
Peng CC; Burke MT; Carbia BE; Plummer C; Chauhan A
J Control Release; 2012 Aug; 162(1):152-8. PubMed ID: 22721817
[TBL] [Abstract][Full Text] [Related]
8. Drug delivery by contact lens in spontaneously glaucomatous dogs.
Peng CC; Ben-Shlomo A; Mackay EO; Plummer CE; Chauhan A
Curr Eye Res; 2012 Mar; 37(3):204-11. PubMed ID: 22335807
[TBL] [Abstract][Full Text] [Related]
9. Multiple drug delivery from the drug-implants-laden silicone contact lens: Addressing the issue of burst drug release.
Desai AR; Maulvi FA; Desai DM; Shukla MR; Ranch KM; Vyas BA; Shah SA; Sandeman S; Shah DO
Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110885. PubMed ID: 32409042
[TBL] [Abstract][Full Text] [Related]
10. Effect of gold nanoparticles on timolol uptake and its release kinetics from contact lenses: In vitro and in vivo evaluation.
Maulvi FA; Patil RJ; Desai AR; Shukla MR; Vaidya RJ; Ranch KM; Vyas BA; Shah SA; Shah DO
Acta Biomater; 2019 Mar; 86():350-362. PubMed ID: 30625414
[TBL] [Abstract][Full Text] [Related]
11. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
Michaud JE; Friren B;
Am J Ophthalmol; 2001 Aug; 132(2):235-43. PubMed ID: 11476685
[TBL] [Abstract][Full Text] [Related]
12. Temperature sensitive contact lenses for triggered ophthalmic drug delivery.
Jung HJ; Chauhan A
Biomaterials; 2012 Mar; 33(7):2289-300. PubMed ID: 22182750
[TBL] [Abstract][Full Text] [Related]
13. Glaucoma therapy by extended release of timolol from nanoparticle loaded silicone-hydrogel contact lenses.
Jung HJ; Abou-Jaoude M; Carbia BE; Plummer C; Chauhan A
J Control Release; 2013 Jan; 165(1):82-9. PubMed ID: 23123188
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of modified lens using plasma treatment containing timolol-maleate loaded lauric acid-decorated chitosan-alginate nanoparticles for glaucoma.
Hosseini MS; Mohseni M; Naseripour M; Mirzaei M; Bagherzadeh K; Alemezadeh SA; Mehravi B
J Biomater Sci Polym Ed; 2023 Oct; 34(13):1793-1812. PubMed ID: 36872905
[TBL] [Abstract][Full Text] [Related]
15. Fabrication and Characterization of Timolol Maleate and Brinzolamide Loaded Nanostructured Lipid Carrier System for Ocular Drug Delivery.
Shrivastava N; Khan S; Baboota S; Ali J
Curr Drug Deliv; 2018; 15(6):829-839. PubMed ID: 29189155
[TBL] [Abstract][Full Text] [Related]
16. Brinzolamide-loaded soft contact lens for ophthalmic delivery.
C De Guzman LM; De Guzman GQ; Borromeo EC
Ther Deliv; 2022 Apr; 13(4):233-247. PubMed ID: 35615865
[No Abstract] [Full Text] [Related]
17. Brinzolamide/timolol fixed combination: a new ocular suspension for the treatment of open-angle glaucoma and ocular hypertension.
Holló G; Bozkurt B; Irkec M
Expert Opin Pharmacother; 2009 Aug; 10(12):2015-24. PubMed ID: 19618994
[TBL] [Abstract][Full Text] [Related]
18. The long-term safety and efficacy of brinzolamide 1.0% (azopt) in patients with primary open-angle glaucoma or ocular hypertension. The Brinzolamide Long-Term Therapy Study Group.
March WF; Ochsner KI
Am J Ophthalmol; 2000 Feb; 129(2):136-43. PubMed ID: 10682964
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of brimonidine loaded silica nanoparticles-laden silicone contact lenses to manage glaucoma.
Xu Y; Li H
J Biomater Appl; 2022 Aug; 37(2):333-343. PubMed ID: 35482359
[TBL] [Abstract][Full Text] [Related]
20. Intraocular pressure reduction with travoprost/timolol fixed combination, with and without adjunctive brinzolamide, in glaucoma.
Holló G; Kóthy P
Curr Med Res Opin; 2008 Jun; 24(6):1755-61. PubMed ID: 18479590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
